Form 8-K - Current report:
SEC Accession No. 0001102624-12-000529
Filing Date
2012-06-19
Accepted
2012-06-19 08:02:47
Documents
2
Period of Report
2012-06-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 IMMUCELL CORPORATION 8-K immucellcorporation8k.htm 8-K 4689
2 IMMUCELL CORPORATION PRESS RELEASE immucellcorporation.htm EX-99 1413
  Complete submission text file 0001102624-12-000529.txt   7158
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 12913755
SIC: 2835 In Vitro & In Vivo Diagnostic Substances